CA3178537A1 - Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein - Google Patents

Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein Download PDF

Info

Publication number
CA3178537A1
CA3178537A1 CA3178537A CA3178537A CA3178537A1 CA 3178537 A1 CA3178537 A1 CA 3178537A1 CA 3178537 A CA3178537 A CA 3178537A CA 3178537 A CA3178537 A CA 3178537A CA 3178537 A1 CA3178537 A1 CA 3178537A1
Authority
CA
Canada
Prior art keywords
pep16
cells
pathway
results
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3178537A
Other languages
English (en)
French (fr)
Inventor
Frederic CAILOTTO
Marion Claudel
Christophe Charron
Jean-Yves Jouzeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National Polytechnique de Lorraine
Centre Hospitalier Universitaire de Nancy
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA3178537A1 publication Critical patent/CA3178537A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA3178537A 2020-05-18 2021-05-18 Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein Pending CA3178537A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20315243.4 2020-05-18
EP20315243.4A EP3912991A1 (en) 2020-05-18 2020-05-18 Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein
PCT/EP2021/063109 WO2021233896A1 (en) 2020-05-18 2021-05-18 Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein

Publications (1)

Publication Number Publication Date
CA3178537A1 true CA3178537A1 (en) 2021-11-25

Family

ID=71607831

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3178537A Pending CA3178537A1 (en) 2020-05-18 2021-05-18 Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein

Country Status (6)

Country Link
US (1) US20230183303A1 (https=)
EP (2) EP3912991A1 (https=)
JP (1) JP2023541087A (https=)
CN (1) CN115996944A (https=)
CA (1) CA3178537A1 (https=)
WO (1) WO2021233896A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202401058D0 (en) * 2024-01-26 2024-03-13 Univ London Queen Mary Treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
EP1498133A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma Deutschland GmbH Use of a pak inhibitor for the treatment of a joint disease
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
WO2015176066A2 (en) * 2014-05-16 2015-11-19 Intermune, Inc. Lpa-associated protein and rna expression
JP5967685B1 (ja) * 2016-01-13 2016-08-10 国立大学法人名古屋大学 軟骨細胞のＷｎｔ／β−カテニンシグナル伝達経路の活性化抑制組成物及び変形性関節症治療用医薬組成物
FR3051192B1 (fr) 2016-05-13 2020-12-25 Univ De Lorraine Methode de purification de proteines recombinantes par affinite basee sur l'activite lectinique du domaine crd d'une galectine

Also Published As

Publication number Publication date
US20230183303A1 (en) 2023-06-15
EP4153611A1 (en) 2023-03-29
EP3912991A1 (en) 2021-11-24
CN115996944A (zh) 2023-04-21
WO2021233896A1 (en) 2021-11-25
JP2023541087A (ja) 2023-09-28

Similar Documents

Publication Publication Date Title
Jeon et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation
Yasuhara et al. Wnt/β-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover
Jogo et al. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase
Zou et al. In vitro study of enhanced osteogenesis induced by HIF‐1α‐transduced bone marrow stem cells
Xing et al. Genetic evidence that thyroid hormone is indispensable for prepubertal insulin‐like growth factor–I expression and bone acquisition in mice
Yamamoto et al. Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition
Zhao et al. Cathepsin K: a therapeutic target for bone diseases
Zhu et al. The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation
Ericsson et al. YY1 is a negative regulator of transcription of three sterol regulatory element-binding protein-responsive genes
Sohaskey et al. Osteopotentia regulates osteoblast maturation, bone formation, and skeletal integrity in mice
Chen et al. Abnormal osteogenic and chondrogenic differentiation of human mesenchymal stem cells from patients with adolescent idiopathic scoliosis in response to melatonin
Li et al. Primary cilia respond to intermittent low-magnitude, high-frequency vibration and mediate vibration-induced effects in osteoblasts
Zheng et al. Promotive role of CircATRNL1 on chondrogenic differentiation of BMSCs mediated by miR-338-3p
Zhang et al. Neuropeptide Y upregulates Runx2 and osterix and enhances osteogenesis in mouse MC3T3-E1 cells via an autocrine mechanism
Yang et al. MALAT1 enhanced the proliferation of human osteoblasts treated with ultra‑high molecular weight polyethylene by targeting VEGF via miR‑22‑5p
Ma et al. Knockdown of peroxiredoxin 5 inhibits the growth of osteoarthritic chondrocytes via upregulating Wnt/β-catenin signaling
Liu et al. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment
Ma et al. Ribosomal L1 domain and lysine-rich region are essential for CSIG/RSL1D1 to regulate proliferation and senescence
US20230183303A1 (en) Therapeutic Potential of Peptides from the "Netrin-Like" Domain of the FRZB Protein
Zhao et al. MicroRNA-204-5p inhibits the osteogenic differentiation of ankylosing spondylitis fibroblasts by regulating the Notch2 signaling pathway
Peters Cytosolic (pro) renin and the matter of intracellular renin actions
Goomer et al. The tetrabasic KKKK147–150 motif determines intracrine regulatory effects of PTHrP 1–173 on chondrocyte PPi metabolism and matrix synthesis
Yeh et al. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation
Le Jeune et al. Identification of four alternatively spliced transcripts of the Ucma/GRP gene, encoding a new Gla-containing protein
Luan et al. Taladegib controls early chondrocyte hypertrophy via inhibiting smoothened/Gli1 pathway

Legal Events

Date Code Title Description
D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20250401

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250401

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250502

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250507

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250508

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250508

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250520